CSIMarket Company Name, Ticker, Customers, else..
 
Fennec Pharmaceuticals Inc   (NASDAQ: FENC)
 

Fennec Pharmaceuticals Inc's Suppliers Performance

FENC's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
FENC Costs vs Sales of Suppliers Growth

• More on FENC Suppliers






Fennec Pharmaceuticals Inc's Comment on Supply Chain


The company utilizes third-party suppliers and contract manufacturers for raw materials, clinical trials, and the production of PEDMARK®. Key development partners include Norgine Pharma UK Limited in Europe and Inpharmus (formerly TRPharm İlaç Sanayi Ticaret A.Ş. and TRPharm FZ-LLC) in Turkey and the Gulf Cooperation Council countries. The performance of these partners is essential for securing regulatory approvals and commercializing PEDMARK® outside the United States. Noncompliance by these third parties with legal, regulatory, or manufacturing standards could significantly impact the company's operations.

Fennec Pharmaceuticals Inc's Comment on Supply Chain


The company utilizes third-party suppliers and contract manufacturers for raw materials, clinical trials, and the production of PEDMARK®. Key development partners include Norgine Pharma UK Limited in Europe and Inpharmus (formerly TRPharm İlaç Sanayi Ticaret A.Ş. and TRPharm FZ-LLC) in Turkey and the Gulf Cooperation Council countries. The performance of these partners is essential for securing regulatory approvals and commercializing PEDMARK® outside the United States. Noncompliance by these third parties with legal, regulatory, or manufacturing standards could significantly impact the company's operations.







FENC's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Fennec Pharmaceuticals Inc 437.60 51.00 -8.38 35
SUBTOTAL 0.00 0.00 0.00 -


Sources: Fennec Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Fennec Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.